Licensing agreement announced for sutezolid drug for TB
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Mar, 2017
TB Alliance and Medicines Patent Pool announced a licensing agreement for the clinical development of sutezolid. It is a...Read more
Astex Pharma cancer drug receives US marketing approval
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2017
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule thera...Read more
Chugai receives Taiwan nod for Alecensa
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2017
Singapore: Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan has re...Read more
TimeBlock - to reverse biological ageing launches in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2017
For thousands of years, humans have been on a quest to combat the process of degenerative ageing and find the secret of ...Read more
Australia approves drug that can 'melt away' cancer cells
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2017
Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away...Read more
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2016
Boehringer Ingelheim announced new data from the Phase I INVICTAN-1 study, which show that BI 695502, its bevacizumab bi...Read more
NUS scientists discover the switch that makes breast cancer cells aggressive
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2016
Singapore: A team of scientists from National University of Singapore (NUS) has established novel insights into the rel...Read more
"Prevalence of COPD in Asia is similar to western countries"
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 27 Oct, 2016
GlaxoSmithKline and biopharmaceutical company, Innoviva, have concluded Salford Lung Study (SLS), a Phase IIIb multi-cen...Read more
Singapore develops oral-anti-diabetic drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Oct, 2016
Singapore: Singapore has completed phase I clinical trial of an oral-anti-diabetic drug developed by Department of Pharm...Read more
South Korea's Hanmi pharmaceuticals in troubled waters!
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2016
Singapore: New blockbuster cancer drug from South Korea's Hanmi pharmaceuticals is in troubled waters after a patient di...Read more
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 04 Oct, 2016
Singapore: Waters Corporation recently collaborated with Bioprocessing Technology Institute (BTI), a research institute ...Read more
Renowned neurologist, Allen Roses, passes away
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 05 Oct, 2016
Singapore: Allen David Roses, a renowned neurologist who pioneered breakthrough research in Alzhiemer's Disease, passed ...Read more
Australia changes drug approval norms to speed up approval process
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2016
Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal...Read more
Semaglutide reduces risk of cardiovascular problems among type 2 Diabetic patients
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2016
Munich: Danish Drug maker Novo Nordisk recently announced that patients treated with Semaglutide, an investigational glu...Read more
Eisai receives license for new indication for anticancer agent Kisplyx
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2016
TOKYO: Eisai Co., Ltd. announced that its European regional headquarters Eisai Europe Ltd. has received license from the...Read more
Singapore develops new protein to alter DNA in living cells
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2016
Singapore: Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher pre...Read more
Glenmark receives ANDA approval for Nystatin, Triamcinolone Acetonide ointment
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2016
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food & Drug Administrat...Read more
Novogen progresses on drugs against genetic, degenerative disorders
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a ...Read more